Skip to content
Sign in

QLTY · ARCA · ETF

GMO U.S. Quality ETF (QLTY) Price, Holdings & Fees

$295.78−0.43%−$1.29End-of-day price as of Oct 9, 2026

GMO U.S. Quality ETF (QLTY) closed at $295.78 on Oct 9, 2026, down 0.43% from the previous close of $297.07.

Share price, past year

1Y +52.84%

52-week range $192.27 – $297.07. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$295.78
Sep 30, 2026$286.56
Aug 31, 2026$280.54
Jul 31, 2026$277.57
Jun 30, 2026$279.06
May 29, 2026$250.98
Apr 30, 2026$249.44
Mar 31, 2026$237.20
Feb 27, 2026$248.15
Jan 30, 2026$233.90
Dec 31, 2025$223.47
Nov 28, 2025$212.94
Oct 31, 2025$202.34

Key statistics

Expense ratio
0.50%
as of Feb 28, 2026
Net assets
$4.5B
as of May 31, 2026
Holdings
42
as of May 31, 2026
52-week range
$192.27 – $297.07

GMO U.S. Quality ETF's expense ratio is 0.50%: $50.00 a year on $10,000 invested.

Holdings

GMO U.S. Quality ETF held 42 investments worth $4.51B as of May 31, 2026. Its largest holding was Microsoft Corp, at 7.17% of the fund.

GMO U.S. Quality ETF largest holdings by share of net assets
#Holding% of fundValue
1Microsoft Corp7.17%$323.29M
2Alphabet Inc5.64%$254.19M
3Lam Research Corp5.38%$242.23M
4Apple Inc5.12%$230.56M
5Broadcom Inc4.79%$215.72M
6Texas Instruments Inc4.44%$199.88M
7Meta Platforms Inc4.31%$194.44M
8Johnson & Johnson4.22%$190.24M
9KLA Corp3.98%$179.15M
10Amazon.com Inc3.90%$175.86M
11Thermo Fisher Scientific Inc2.94%$132.60M
12UnitedHealth Group Inc2.85%$128.21M
13Visa Inc2.58%$116.37M
14Salesforce Inc2.54%$114.41M
15Eli Lilly & Co2.52%$113.45M
16Aramark2.48%$111.92M
17US Bancorp2.46%$110.66M
18Procter & Gamble Co/The2.35%$105.74M
19Abbott Laboratories2.29%$103.11M
20Accenture PLC2.29%$103.10M
21Hilton Worldwide Holdings Inc2.08%$93.72M
22Merck & Co Inc1.83%$82.45M
23General Electric Co1.79%$80.54M
24Mastercard Inc1.78%$80.23M
25Coca-Cola Co/The1.76%$79.48M

Top 25 of 42 holdings, as of May 31, 2026. Percentages are of the fund's net assets.

What the fund owns

GMO U.S. Quality ETF holdings by asset type
Asset type% of fund
Stocks99.69%
Cash and short-term investments0.29%
GMO U.S. Quality ETF holdings by country, largest 2
Country% of fund
United States97.69%
Ireland2.29%

Shares of net assets from the fund's N-PORT report. Funds that borrow can add up to more than 100%, with borrowing (such as repurchase agreements) shown as a negative share.

Monthly total returns

Over the 3 months to May 31, 2026, GMO U.S. Quality ETF's total return was +7.28%, as reported to the SEC.

GMO U.S. Quality ETF monthly total returns
MonthTotal return
May 31, 2026+4.21%
Apr 30, 2026+9.97%
Mar 31, 2026−6.39%

The fund's own total returns as reported to the SEC (N-PORT), including reinvested distributions. Not the sample prices above.

Fund profile

Name
GMO U.S. Quality ETF
Ticker
QLTY
Exchange
ARCA
Fund type
ETF
Trust
GMO ETF Trust
SEC series ID
S000082992
SEC CIK
0001981627
Fractional shares
Yes

Recent SEC filings

Shareholder reports and prospectuses are filed by GMO ETF Trust, the trust behind GMO U.S. Quality ETF, and cover all of its funds.

Frequently asked questions

What is QLTY's price?

GMO U.S. Quality ETF (QLTY) closed at $295.78 on Oct 9, 2026, down 0.43% from the previous close of $297.07.

What is QLTY's expense ratio?

GMO U.S. Quality ETF's expense ratio is 0.50%: $50.00 a year on $10,000 invested.

What does QLTY hold?

GMO U.S. Quality ETF held 42 investments worth $4.51B as of May 31, 2026. Its largest holding was Microsoft Corp, at 7.17% of the fund. Its five largest holdings were Microsoft Corp, Alphabet Inc, Lam Research Corp, Apple Inc, Broadcom Inc.

How has QLTY performed?

Over the 3 months to May 31, 2026, GMO U.S. Quality ETF's total return was +7.28%, as reported to the SEC.

Sources and methodology

Holdings, net assets and monthly returns come from the fund's N-PORT filing with the SEC, as of May 31, 2026 (filed Jul 29, 2026). The expense ratio is from the fund's prospectus or shareholder report, as of Feb 28, 2026. Prices are generated sample data for development. Data sources and disclosures